Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7376
    -0.0010 (-0.14%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    95,331.95
    +371.64 (+0.39%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,379.46
    -20.06 (-0.12%)
     
  • VOLATILITY

    13.01
    +0.23 (+1.80%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • CAD/EUR

    0.6844
    +0.0001 (+0.01%)
     

Free Research Report as Monsanto’s Revenue Grew 0.3%, EPS Soared 442.9%

LONDON, UK / ACCESSWIRE / January 17, 2018 / Active-Investors.com has just released a free earnings report on Monsanto Co. (NYSE: MON). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=MON. The Company posted its financial results on January 04, 2018, for the first quarter fiscal 2018. The agricultural products Company's adjusted EPS surpassed analysts' expectations. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Monsanto most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=MON

ADVERTISEMENT

Earnings Highlights and Summary

For three months ended November 30, 2017, Monsanto's total net revenues increased 0.3% to $2.66 billion from $2.65 billion in Q1 FY17. The Company's total revenue was below analysts' expectations of $2.77 billion.

For the reported quarter, the Company's gross profit increased 4.2% to $1.31 billion from $1.26 billion in Q1 FY17. For the reported quarter, the Company's gross margin increased 190 basis points to 49.4% of revenue from 47.5% of revenue in Q1 FY17. For the reported quarter, the Company's adjusted gross margin increased 230 basis points to 49.8% of revenue from 47.5% of revenue in Q1 FY17.

For the reported quarter, the Company's operating income decreased 2% to $242 million from $247 million in Q1 FY17. For the reported quarter, the Company's operating margin decreased 20 basis points to 9.1% of revenue from 9.3% of revenue in Q1 FY17.

During Q1 FY18, Monsanto's earnings before tax (EBT) decreased 167.4% to $230 million from $86 million in the same period last year. For the reported quarter, the Company's EBT margin increased 550 basis points to 8.7% of revenue from 3.2% of revenue in Q1 FY17.

For the reported quarter, Monsanto's net income increased 482.8% to $169 million on a y-o-y basis from $29 million in Q1 FY17. During Q1 FY18, the Company's diluted earnings per share (EPS) increased 442.9% to $0.38 on a y-o-y basis from $0.07 in the same period last year. For the reported quarter, Monsanto's adjusted net income increased 101.1% to $183 million on a y-o-y basis from $91 million in Q1 FY17. During Q1 FY18, the Company's adjusted diluted EPS increased 95.2% to $0.41 on a y-o-y basis from $0.21 in the same period last year. Adjusted diluted EPS surpassed analysts' expectations of $0.38.

Monsanto's Segment Details

Seeds and Genomics - During Q1 FY18, the Seeds and Genomics segment's net revenue decreased 4.2% to $1.77 billion from $1.85 billion in the same period last year. For the reported quarter, the segment's gross profit decreased 0.7% to $1.13 billion from $1.14 billion in Q1 FY17.

Agricultural Productivity - During Q1 FY18, the Agricultural Productivity segment's net revenue increased 10.7% to $888 million from $802 million in the same period last year. For the reported quarter, the segment's gross profit increased 51.3% to $180 million from $119 million in Q1 FY17.

Balance Sheet

As on November 30, 2017, Monsanto's cash and cash equivalents increased 67.1% to $3.10 billion, from $1.86 billion on August 31, 2017. For the reported quarter, the Company's long-term debt decreased 4.2% to $6.95 billion from $7.25 billion in Q4 FY17.

For the reported quarter, the Company's net trade receivable decreased 2.1% to $2.12 billion from $2.16 billion in Q4 FY17. For the reported quarter, Monsanto's accounts payable increased 11.8% to $1.19 billion from $1.07 billion in Q4 FY17.

During Q1 FY18, the Company's net cash provided by operating activities decreased 11.7% to $1.29 billion from $1.46 billion in the same period last year. During Q1 FY18, the Company's free cash flow decreased 23.7% to $874 million from $1.15 billion in the same period last year. The decrease was primarily due to increased outflows from accruals, market funding and incentive payments stemming from the growth in the business in last year as well as an increase in CapEx as the Company ramp up its dicamba plant investments.

Stock Performance Snapshot

January 16, 2018 - At Tuesday's closing bell, Monsanto's stock slightly advanced 0.02%, ending the trading session at $119.72.

Volume traded for the day: 4.08 million shares, which was above the 3-month average volume of 2.75 million shares.

Stock performance in the last month – up 1.38%; previous six-month period – up 2.04%; past twelve-month period – up 11.24%; and year-to-date – up 2.52%

After yesterday's close, Monsanto's market cap was at $52.70 billion.

Price to Earnings (P/E) ratio was at 23.59.

The stock has a dividend yield of 1.80%.

The stock is part of the Basic Materials sector, categorized under the Agricultural Chemicals industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors